THERAPEUTIC AGENT FOR CEREBRAL INFARCTION

摘要

It is intended to provide a novel therapeutic agent for cerebral infarction containing a piperazine compound as an active ingredient. The compound according to the invention can be formulated into a novel therapeutic agent for cerebral infarction having an effect of reducing the volume of brain injury or improving neurologic symptoms by suppressing the production of a plurality of inflammatory cytokines and chemokines present in the brain such as TNF-a, IL-1ß, IL-6 and MCP-1.